Annual Interest Expense
$855.00 M
+$55.00 M+6.88%
31 December 2023
Summary:
Novartis AG annual interest expense is currently $855.00 million, with the most recent change of +$55.00 million (+6.88%) on 31 December 2023. During the last 3 years, it has fallen by -$14.00 million (-1.61%). NVS annual interest expense is now -8.26% below its all-time high of $932.00 million, reached on 31 December 2018.NVS Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$264.00 M
+$18.00 M+7.32%
30 September 2024
Summary:
Novartis AG quarterly interest expense is currently $264.00 million, with the most recent change of +$18.00 million (+7.32%) on 30 September 2024. Over the past year, it has increased by +$42.00 million (+18.92%). NVS quarterly interest expense is now at all-time high.NVS Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$948.00 M
+$42.00 M+4.64%
30 September 2024
Summary:
Novartis AG TTM interest expense is currently $948.00 million, with the most recent change of +$42.00 million (+4.64%) on 30 September 2024. Over the past year, it has increased by +$103.00 million (+12.19%). NVS TTM interest expense is now at all-time high.NVS TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVS Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.9% | +18.9% | +12.2% |
| 3 y3 years | -1.6% | +30.7% | +17.6% |
| 5 y5 years | -8.3% | +22.2% | +5.9% |
NVS Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1.6% | +8.6% | at high | +45.0% | at high | +20.6% |
| 5 y | 5 years | -8.3% | +8.6% | at high | +45.0% | at high | +20.6% |
| alltime | all time | -8.3% | +340.7% | at high | +332.8% | at high | +1454.1% |
Novartis AG Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $264.00 M(+7.3%) | $948.00 M(+4.6%) |
| June 2024 | - | $246.00 M(+11.3%) | $906.00 M(+3.4%) |
| Mar 2024 | - | $221.00 M(+1.8%) | $876.00 M(+2.5%) |
| Dec 2023 | $855.00 M(+6.9%) | $217.00 M(-2.3%) | $855.00 M(+1.2%) |
| Sept 2023 | - | $222.00 M(+2.8%) | $845.00 M(+1.9%) |
| June 2023 | - | $216.00 M(+8.0%) | $829.00 M(+1.7%) |
| Mar 2023 | - | $200.00 M(-3.4%) | $815.00 M(-0.1%) |
| Dec 2022 | $800.00 M(+1.7%) | $207.00 M(+0.5%) | $816.00 M(+3.2%) |
| Sept 2022 | - | $206.00 M(+2.0%) | $791.00 M(+0.5%) |
| June 2022 | - | $202.00 M(+0.5%) | $787.00 M(+0.1%) |
| Mar 2022 | - | $201.00 M(+10.4%) | $786.00 M(-0.1%) |
| Dec 2021 | $787.00 M(-9.4%) | $182.00 M(-9.9%) | $787.00 M(-2.4%) |
| Sept 2021 | - | $202.00 M(+0.5%) | $806.00 M(-0.9%) |
| June 2021 | - | $201.00 M(-0.5%) | $813.00 M(-2.3%) |
| Mar 2021 | - | $202.00 M(+0.5%) | $832.00 M(-4.3%) |
| Dec 2020 | $869.00 M(+2.2%) | $201.00 M(-3.8%) | $869.00 M(-0.2%) |
| Sept 2020 | - | $209.00 M(-5.0%) | $871.00 M(-0.8%) |
| June 2020 | - | $220.00 M(-7.9%) | $878.00 M(+1.7%) |
| Mar 2020 | - | $239.00 M(+17.7%) | $863.00 M(+1.5%) |
| Dec 2019 | $850.00 M(-8.8%) | $203.00 M(-6.0%) | $850.00 M(-5.0%) |
| Sept 2019 | - | $216.00 M(+5.4%) | $895.00 M(-1.4%) |
| June 2019 | - | $205.00 M(-9.3%) | $908.00 M(-3.4%) |
| Mar 2019 | - | $226.00 M(-8.9%) | $940.00 M(+0.9%) |
| Dec 2018 | $932.00 M(+24.3%) | $248.00 M(+8.3%) | $932.00 M(+7.7%) |
| Sept 2018 | - | $229.00 M(-3.4%) | $865.00 M(+3.8%) |
| June 2018 | - | $237.00 M(+8.7%) | $833.00 M(+5.7%) |
| Mar 2018 | - | $218.00 M(+20.4%) | $788.00 M(+5.1%) |
| Dec 2017 | $750.00 M(+6.1%) | $181.00 M(-8.1%) | $750.00 M(+1.8%) |
| Sept 2017 | - | $197.00 M(+2.6%) | $737.00 M(+3.2%) |
| June 2017 | - | $192.00 M(+6.7%) | $714.00 M(+1.7%) |
| Mar 2017 | - | $180.00 M(+7.1%) | $702.00 M(-0.7%) |
| Dec 2016 | $707.00 M(+7.9%) | $168.00 M(-3.4%) | $707.00 M(+1.4%) |
| Sept 2016 | - | $174.00 M(-3.3%) | $697.00 M(+3.0%) |
| June 2016 | - | $180.00 M(-2.7%) | $677.00 M(+2.4%) |
| Mar 2016 | - | $185.00 M(+17.1%) | $661.00 M(+0.9%) |
| Dec 2015 | $655.00 M | $158.00 M(+2.6%) | $655.00 M(-4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2015 | - | $154.00 M(-6.1%) | $685.00 M(-3.9%) |
| June 2015 | - | $164.00 M(-8.4%) | $713.00 M(-0.3%) |
| Mar 2015 | - | $179.00 M(-4.8%) | $715.00 M(+1.6%) |
| Dec 2014 | $704.00 M(+3.1%) | $188.00 M(+3.3%) | $704.00 M(+3.7%) |
| Sept 2014 | - | $182.00 M(+9.6%) | $679.00 M(+1.8%) |
| June 2014 | - | $166.00 M(-1.2%) | $667.00 M(-1.3%) |
| Mar 2014 | - | $168.00 M(+3.1%) | $676.00 M(-1.0%) |
| Dec 2013 | $683.00 M(-5.7%) | $163.00 M(-4.1%) | $683.00 M(-5.0%) |
| Sept 2013 | - | $170.00 M(-2.9%) | $719.00 M(-1.1%) |
| June 2013 | - | $175.00 M(0.0%) | $727.00 M(-1.1%) |
| Mar 2013 | - | $175.00 M(-12.1%) | $735.00 M(+1.5%) |
| Dec 2012 | $724.00 M(-3.6%) | $199.00 M(+11.8%) | $724.00 M(+3.6%) |
| Sept 2012 | - | $178.00 M(-2.7%) | $699.00 M(-2.8%) |
| June 2012 | - | $183.00 M(+11.6%) | $719.00 M(-1.0%) |
| Mar 2012 | - | $164.00 M(-5.7%) | $726.00 M(-3.3%) |
| Dec 2011 | $751.00 M(+8.5%) | $174.00 M(-12.1%) | $751.00 M(-2.8%) |
| Sept 2011 | - | $198.00 M(+4.2%) | $773.00 M(+1.3%) |
| June 2011 | - | $190.00 M(+0.5%) | $763.00 M(+2.0%) |
| Mar 2011 | - | $189.00 M(-3.6%) | $748.00 M(+8.1%) |
| Dec 2010 | $692.00 M(+25.6%) | $196.00 M(+4.3%) | $692.00 M(+6.1%) |
| Sept 2010 | - | $188.00 M(+7.4%) | $652.00 M(+2.4%) |
| June 2010 | - | $175.00 M(+31.6%) | $637.00 M(+6.5%) |
| Mar 2010 | - | $133.00 M(-14.7%) | $598.00 M(+8.5%) |
| Dec 2009 | $551.00 M(+90.0%) | $156.00 M(-9.8%) | $551.00 M(+17.0%) |
| Sept 2009 | - | $173.00 M(+27.2%) | $471.00 M(+19.5%) |
| June 2009 | - | $136.00 M(+58.1%) | $394.00 M(+23.5%) |
| Mar 2009 | - | $86.00 M(+13.2%) | $319.00 M(+36.9%) |
| Dec 2008 | $290.00 M(+22.4%) | $76.00 M(-20.8%) | $233.00 M(+48.4%) |
| Sept 2008 | - | $96.00 M(+57.4%) | $157.00 M(+157.4%) |
| June 2008 | - | $61.00 M | $61.00 M |
| Dec 2007 | $237.00 M(-10.9%) | - | - |
| Dec 2006 | $266.00 M(-9.5%) | - | - |
| Dec 2005 | $294.00 M(+12.6%) | - | - |
| Dec 2004 | $261.00 M(+7.4%) | - | - |
| Dec 2003 | $243.00 M(+25.3%) | - | - |
| Dec 2002 | $194.00 M(-11.0%) | - | - |
| Dec 2001 | $218.00 M | - | - |
FAQ
- What is Novartis AG annual interest expense?
- What is the all time high annual interest expense for Novartis AG?
- What is Novartis AG annual interest expense year-on-year change?
- What is Novartis AG quarterly interest expense?
- What is the all time high quarterly interest expense for Novartis AG?
- What is Novartis AG quarterly interest expense year-on-year change?
- What is Novartis AG TTM interest expense?
- What is the all time high TTM interest expense for Novartis AG?
- What is Novartis AG TTM interest expense year-on-year change?
What is Novartis AG annual interest expense?
The current annual interest expense of NVS is $855.00 M
What is the all time high annual interest expense for Novartis AG?
Novartis AG all-time high annual interest expense is $932.00 M
What is Novartis AG annual interest expense year-on-year change?
Over the past year, NVS annual interest expense has changed by +$55.00 M (+6.88%)
What is Novartis AG quarterly interest expense?
The current quarterly interest expense of NVS is $264.00 M
What is the all time high quarterly interest expense for Novartis AG?
Novartis AG all-time high quarterly interest expense is $264.00 M
What is Novartis AG quarterly interest expense year-on-year change?
Over the past year, NVS quarterly interest expense has changed by +$42.00 M (+18.92%)
What is Novartis AG TTM interest expense?
The current TTM interest expense of NVS is $948.00 M
What is the all time high TTM interest expense for Novartis AG?
Novartis AG all-time high TTM interest expense is $948.00 M
What is Novartis AG TTM interest expense year-on-year change?
Over the past year, NVS TTM interest expense has changed by +$103.00 M (+12.19%)